Enara Bio Competitors and Similar CompaniesClear all

Enara Bio's competitors and similar companies include ImmunoGen, Scorpion Therapeutics and Aeglea.

	Enara Bio Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer.	ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.	Scorpion Therapeutics Scorpion Therapeutics is a company that develops cancer treatments.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
Founding Date	Founding Date 2016	Founding Date 1981	Founding Date 2020	Founding Date 2013
Type	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology
Locations	Locations Oxford, GB HQ London, GB London, GB Oxford, GB	Locations Waltham, US HQ	Locations Boston, US HQ Boston, US South San Francisco, US	Locations Austin, US HQ
Employees	Employees 622% increase	Employees 277161% increase	Employees 1213% decrease	Employees 65117% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 8.7 b	Valuation ($) N/A	Valuation ($) 48.6 m
Financial
Net income	Net income N/A	Net income ($222.9m) (FY, 2022)	Net income N/A	Net income ($155.2m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 17.5m (over 6 years ago)	Latest funding round N/A	Latest funding round $ 108m (over 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 17.5m	Total funding raised $ 56m	Total funding raised $ 108m	Total funding raised N/A